Defunct Company
Total Trials
13
As Lead Sponsor
6
As Collaborator
7
Total Enrollment
2,201
NCT00562757
Prospective Study to Identify Patients at Risk of Dangerous Ventricular Arrhythmias
Phase: N/A
Role: Lead Sponsor
Start: Sep 30, 2003
Completion: Oct 31, 2009
NCT00320736
Galantamine for Cognition in People With Schizophrenia
Phase: Phase 4
Role: Collaborator
Start: Jan 31, 2004
Completion: May 31, 2006
NCT00287027
Family Perspectives:Treatment of Psychiatric Illnesses With Atypical Long Acting Injectable Antipsychotic Medication
Start: Feb 28, 2006
Completion: Dec 31, 2006
NCT00374699
Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell Lymphomas
Phase: Phase 1/2
Start: Apr 30, 2006
NCT00982475
Alster Man and Machine: Comparison of Manual and Mechanical Remote Robotic Catheter Ablation for Drug-Refractory Atrial Fibrillation
Start: Sep 30, 2009
Completion: Feb 27, 2018
NCT01054924
Performance Study of the Invendo C20 Colonoscope System in Colorectal Cancer Screening
Start: Nov 30, 2009
Completion: Dec 31, 2009
NCT01182389
A Study of Early Robotic Ablation by Substrate Elimination of Ventricular Tachycardia
Start: Oct 31, 2011
Completion: Feb 29, 2016
NCT01122173
Use of the Hansen Medical System in Patients With Paroxysmal Atrial Fibrillation
Start: Jul 31, 2013
Completion: Apr 30, 2017
NCT01984437
Registry of the Magellan Robotic System
Start: Nov 30, 2013
Completion: Aug 31, 2016
NCT02369692
Embolization Procedures in the Peripheral Vasculature Using the Magellan™ Robotic System
Start: Apr 30, 2014
NCT02279836
Single Arm Post-marketing Study of SC20 Colonoscope
Start: Oct 31, 2014
Completion: Jan 31, 2016
NCT02411071
Clinical Implications of HIV Low-level Viremia at Times of Highly Active Antiretroviral Treatment Regimens
Start: Dec 31, 2014
Completion: Dec 31, 2016
NCT07062354
Combined Amivantamab, Carboplatin and Paclitaxel in Unresectable Locally Recurrent or Metastatic Head and Neck Cancer
Phase: Phase 2
Start: Dec 31, 2025
Completion: Oct 31, 2029